Difference between revisions of "Team:KU Leuven/Research/Results"
Line 334: | Line 334: | ||
<div id="togglefour"> | <div id="togglefour"> | ||
<p> | <p> | ||
− | In the first step, the <i>Chromobacterium violacein</i> CV026 was grown with different concentrations of OHHL. The <i>C. violacein</i> CV026 was added to the mixtures at an OD of 1.11. Our cells were grown for 24 hours in air-lid culture tubes at 30 °C in a shaking incubator (200 rpm). In | + | In the first step, the <i>Chromobacterium violacein</i> CV026 was grown with different concentrations of OHHL. The <i>C. violacein</i> CV026 was added to the mixtures at an OD of 1.11. Our cells were grown for 24 hours in air-lid culture tubes at 30 °C in a shaking incubator (200 rpm). In Figure 16 is clearly visible that a violet pigment is produced. </p> |
<div class ="center"> | <div class ="center"> | ||
Line 342: | Line 342: | ||
<img class="example-image" src="https://static.igem.org/mediawiki/2015/d/d2/KU_Leuven_ResultOHHL1.jpeg" width="50%"></a> | <img class="example-image" src="https://static.igem.org/mediawiki/2015/d/d2/KU_Leuven_ResultOHHL1.jpeg" width="50%"></a> | ||
<h4> | <h4> | ||
− | <div id= | + | <div id=figure16>Figure 16</div> |
Culture tubes of inoculated <i>Chromobacterium violacein</i> CV026 with different amounts of OHHL. click to enlarge</h4> | Culture tubes of inoculated <i>Chromobacterium violacein</i> CV026 with different amounts of OHHL. click to enlarge</h4> | ||
</div> | </div> | ||
</div> | </div> | ||
− | <p> First the OD of our cultures were measured in a cuvette (1 cm). Then the violacein is isolated from the cells by centrifugation, resuspension in DMSO and a second centrifugation. | + | <p> First the OD of our cultures were measured in a cuvette (1 cm). Then the violacein is isolated from the cells by centrifugation, resuspension in DMSO and a second centrifugation (Figure 17). |
</p> | </p> | ||
Line 356: | Line 356: | ||
<img class="example-image" src="https://static.igem.org/mediawiki/2015/8/84/KU_Leuven_ResultOHHL2.jpeg" width="50%"></a> | <img class="example-image" src="https://static.igem.org/mediawiki/2015/8/84/KU_Leuven_ResultOHHL2.jpeg" width="50%"></a> | ||
<h4> | <h4> | ||
− | <div id= | + | <div id=figure17>Figure 17</div> |
Violacein will be removed out of our samples by centrifugation and resuspension in DMSO. Click to enlarge</h4> | Violacein will be removed out of our samples by centrifugation and resuspension in DMSO. Click to enlarge</h4> | ||
</div> | </div> | ||
</div> | </div> | ||
− | <p>After isolating violacein from our samples, 200 µL was pipetted into a 96-well falcon microtiter plate and measured at 585 nm. In total, three technical replicates were measured to estimate the pipetting and measuring error ( | + | <p>After isolating violacein from our samples, 200 µL was pipetted into a 96-well falcon microtiter plate and measured at 585 nm. In total, three technical replicates were measured to estimate the pipetting and measuring error (Figure 18). |
</p> | </p> | ||
Line 370: | Line 370: | ||
<img class="example-image" src="https://static.igem.org/mediawiki/2015/5/5f/KU_Leuven_ResultOHHL.jpg" width="50%"></a> | <img class="example-image" src="https://static.igem.org/mediawiki/2015/5/5f/KU_Leuven_ResultOHHL.jpg" width="50%"></a> | ||
<h4> | <h4> | ||
− | <div id= | + | <div id=figure18>Figure 18</div> |
96-well falcon microtiter plate containing the three technical replicates of the dilution series. Click to enlarge</h4> | 96-well falcon microtiter plate containing the three technical replicates of the dilution series. Click to enlarge</h4> | ||
</div> | </div> | ||
</div> | </div> | ||
− | <p>First a broad concentration range was used to estimate the linear part. This range was made by a two-fold dilution series. When measuring the absorbance, LB medium was used as blank. Later the absorbance values of the blank were subtracted from the absorbance values of the standards. Then these values were divided by the absorbance values at 600 nm measured in the microtiterplate which gives an indication of the cell number. Eventually the values were corrected by setting the point with a concentration of 0 mM OHHL in the origin. These values were plotted in figure | + | <p>First a broad concentration range was used to estimate the linear part. This range was made by a two-fold dilution series. When measuring the absorbance, LB medium was used as blank. Later the absorbance values of the blank were subtracted from the absorbance values of the standards. Then these values were divided by the absorbance values at 600 nm measured in the microtiterplate which gives an indication of the cell number. Eventually the values were corrected by setting the point with a concentration of 0 mM OHHL in the origin. These values were plotted in figure 19. The concentrations 2.56 mM and 5.12 mM were left out because these values were not distinguishable from the blank. This can be explained because the OHHL is dissolved in DMSO which lowers the growth of <i>C. violaceum</i> CV026. Between the concentrations 0.64 mM and 1.28 mM, the curve is stagnating. This is probably due to saturation of the medium or the inhibitory effect of DMSO. In a next step, a more narrow range was investigated. |
</p> | </p> | ||
<div class ="center"> | <div class ="center"> | ||
Line 383: | Line 383: | ||
<img class="example-image" src="https://static.igem.org/mediawiki/2015/2/24/KU_Leuven_ResultOHHL4.jpeg" width="50%"></a> | <img class="example-image" src="https://static.igem.org/mediawiki/2015/2/24/KU_Leuven_ResultOHHL4.jpeg" width="50%"></a> | ||
<h4> | <h4> | ||
− | <div id= | + | <div id=figure19>Figure 19</div> |
First estimation of the OHHL standard curve. click to enlarge</h4> | First estimation of the OHHL standard curve. click to enlarge</h4> | ||
</div> | </div> | ||
Line 486: | Line 486: | ||
</div></div> | </div></div> | ||
− | <p>In figure | + | <p>In figure 20, our standard curve is plotted. A linear correlation between the absorbance and the concentration OHHL can be found. The variance of the technical replicates, visualised by the error bars, and the variance of the regression curve, shown by the R^2 value, can be explained by pipetting and measuring errors. Also, working with biological cells generates a background noise. This standard curve could give an estimation of bacterial AHL production. But it is important to keep in mind that there is background noise. Optimisation of this curve can be done by making more biological and technical replicas. |
</p> | </p> | ||
Line 495: | Line 495: | ||
<img class="example-image" src="https://static.igem.org/mediawiki/2015/8/89/KU_Leuven_ResultOHHL5.png" width="50%"></a> | <img class="example-image" src="https://static.igem.org/mediawiki/2015/8/89/KU_Leuven_ResultOHHL5.png" width="50%"></a> | ||
<h4> | <h4> | ||
− | <div id= | + | <div id=figure20>Figure 20</div> |
Standard curve ranging from 0 to 0.1 mM. The error bars represent the standard deviation between the technical replicates.</h4> | Standard curve ranging from 0 to 0.1 mM. The error bars represent the standard deviation between the technical replicates.</h4> | ||
</div> | </div> | ||
Line 531: | Line 531: | ||
BBa_J23101 was transformed in <i>E. cloni</i> to multiply the amount of vector DNA. | BBa_J23101 was transformed in <i>E. cloni</i> to multiply the amount of vector DNA. | ||
After miniprepping, the BioBrick was cut with EagI together with a phosphatase to overcome self-ligation.<br/> | After miniprepping, the BioBrick was cut with EagI together with a phosphatase to overcome self-ligation.<br/> | ||
− | T4 DNA ligase was used and a 1:2 vector-insert ratio was added. Since digestion by EagI does not allow directional cloning, multiple colonies were tested by colony PCR to check insert directionality (Figure | + | T4 DNA ligase was used and a 1:2 vector-insert ratio was added. Since digestion by EagI does not allow directional cloning, multiple colonies were tested by colony PCR to check insert directionality (Figure 21). The correct colonies were selected, miniprepped and sent for sequencing. <br/> |
To characterize the CheZ-GFP BioBrick, the fragment containing a RBS was cloned directly after a strong promotor (BBa_J23101).<br/> | To characterize the CheZ-GFP BioBrick, the fragment containing a RBS was cloned directly after a strong promotor (BBa_J23101).<br/> | ||
− | The presence of colonies expressing GFP proves that the plasmid was designed and cloned correctly. Further characterization could be done by transforming the <i>cheZ</i> knockout Keio strain with this plasmid. These cells should then regain their possibility to swim.</p> | + | The presence of colonies expressing GFP proves that the plasmid was designed and cloned correctly (Figure 22). Further characterization could be done by transforming the <i>cheZ</i> knockout Keio strain with this plasmid. These cells should then regain their possibility to swim.</p> |
<br/> | <br/> | ||
<br/> | <br/> |
Revision as of 02:52, 19 September 2015
Results
Contact
Address: Celestijnenlaan 200G room 00.08 - 3001 Heverlee
Telephone: +32(0)16 32 73 19
Email: igem@chem.kuleuven.be